<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Fri, 12 Dec 2025 11:02:03 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>New Biologic Cleared for Severe Asthma and Nasal Polyps</title><link>https://www.medscape.com/viewarticle/new-biologic-cleared-severe-asthma-and-nasal-polyps-2025a1000yyv?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies. Medscape Medical News</description><pubDate>Fri, 12 Dec 2025 15:52:04 GMT</pubDate></item><item><title>EMA Backs New Option for Hard-to-Treat Bladder Cancer</title><link>https://www.medscape.com/viewarticle/ema-backs-new-option-hard-treat-bladder-cancer-2025a1000yyo?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails. Medscape Medical News</description><pubDate>Fri, 12 Dec 2025 15:34:49 GMT</pubDate></item><item><title>Price of a Life: Is Europeâ€™s Drug Framework Broken?</title><link>https://www.medscape.com/viewarticle/price-life-europes-drug-framework-broken-2025a1000yxv?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who receives transformative treatme...</description><pubDate>Fri, 12 Dec 2025 13:43:34 GMT</pubDate></item><item><title>DLBCL: Older Patients Also Fare Well on Pola-R-CHP</title><link>https://www.medscape.com/viewarticle/dlbcl-older-patients-also-fare-well-pola-r-chp-2025a1000yxl?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Even those older than 80 years benefit from expanded chemotherapy treatment. Medscape Medical News</description><pubDate>Fri, 12 Dec 2025 13:29:35 GMT</pubDate></item><item><title>Semaglutide Lowers SGA-Related Cardiometabolic Risk</title><link>https://www.medscape.com/viewarticle/semaglutide-lowers-antipsychotic-related-cardiometabolic-2025a1000yxa?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk in individuals with schiz...</description><pubDate>Fri, 12 Dec 2025 13:00:18 GMT</pubDate></item></channel></rss>